Media Contacts:
Dave Murdoch
Director of Corporate Communications
774.405.5719
david.murdoch@us.sumitomo-pharma.com
Thomas Hill
VP, Head of Corporate Communications
and Employee Engagement
949.239.3598
thomas.hill@us.sumitomo-pharma.com
News Releases
Stay up to date with SMPA
The latest company news, press releases, and resources about Sumitomo Pharma America, our employees, our partners, and our latest innovations.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 31, 2020•Gedeon Richter to commercialize relugolix combination tablet for uterine fibroids and endometriosis in Europe, Russia – CIS, Latin America, Australia, and New Zealand
BASEL, Switzerland and BUDAPEST, Hungary, March 31, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women’s health...